Jaguar Health (JAGX) Capital Expenditures (QoQ) (2016 - 2026)
Jaguar Health (JAGX) Capital Expenditures (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96.98% |
| Dec 31, 2025 | -866.87% |
| Dec 31, 2024 | -200.00% |
| Sep 30, 2024 | -58.06% |
| Jun 30, 2024 | 202.18% |
| Mar 31, 2024 | -24,400.00% |
| Dec 31, 2023 | -175.00% |
| Sep 30, 2023 | 300.00% |
| Jun 30, 2023 | -111.11% |
| Mar 31, 2023 | 101.37% |
| Dec 31, 2022 | -724.64% |
| Sep 30, 2022 | -82.10% |
| Jun 30, 2022 | 23,480.00% |
| Mar 31, 2022 | -88.37% |
| Jun 30, 2021 | -5.56% |
| Jun 30, 2019 | 225.93% |
| Mar 31, 2019 | 90.47% |
| Dec 31, 2018 | -200.00% |
| Sep 30, 2016 | -52.63% |
| Jun 30, 2016 | -85.37% |